Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Comparison Study of Vinorelbine, Gemcitabine, and Docetaxel Versus Paclitaxel and Carboplatin in Patients With Advanced Non-Small Cell Lung Cancer

NCT00079287 is registered in ClinicalTrials.gov with Japan Multinational Trial Organization as lead sponsor.

NCT NCT00079287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00079287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Comparison Study of Vinorelbine, Gemcitabine, and Docetaxel Versus Paclitaxel and Carboplatin in Patients With Advanced Non-Small Cell Lung Cancer
Lead sponsor
Japan Multinational Trial Organization
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2001
Completion date
November 30, 2008
Enrollment
Not reported
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer